DRK
Sphere 3D Corp.
There isn't enough reported data to score DRK yet.
NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
DRK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
DRK's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
DRK PE Valuation
DRK has no meaningful PE right now: it lost money over the past year.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA's PE is in its cheap range at 21x. If earnings grow as analysts expect, today's price would be 12x next year's earnings.
DRK Forward outlook
There aren't enough analyst estimates for DRK to show an outlook.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
DRK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$7.78 | -$0.53 |
| Q2 2026 | -$8.63 | -$2.93 |
| Q1 2026 | -$5.35 | -$0.05 |
| Q4 2025 | -$7.37 | -$2.57 |
| Q3 2025 | -$7.25 | +$3.80 |
| Q2 2025 | -$5.70 | +$10.40 |
| Q1 2025 | -$5.30 | +$16.20 |
| Q4 2024 | -$4.80 | +$17.50 |
DRK is still losing money, but far less than before: $7.78 per share over the past year, against $22.30 at its worst in late 2023.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over DRK on earnings quality, reporting a profit while its opponent remains loss making.
DRK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3M | +16% |
| Q2 2026 | $2.5M | -19% |
| Q1 2026 | $1.9M | -32% |
| Q4 2025 | $2.7M | +3.1% |
| Q3 2025 | $2.6M | +11% |
| Q2 2025 | $3M | -35% |
| Q1 2025 | $2.8M | -59% |
| Q4 2024 | $2.6M | -66% |
DRK's revenue is recovering but still below its 2023 peak: $3M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -191% | -37 points |
| Q2 2026 | -564% | -477 points |
| Q1 2026 | -216% | -31 points |
| Q4 2025 | -373% | -44 points |
| Q3 2025 | -154% | +65 points |
| Q2 2025 | -87% | +35 points |
| Q1 2025 | -184% | -157 points |
| Q4 2024 | -329% | -132 points |
DRK's operating margin was −191% last quarter, down 37 points from the same quarter a year ago.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over DRK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over DRK on profitability, with a higher operating margin.
DRK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4.5M | +$1.3M |
| Q2 2026 | -$5.3M | +$745K |
| Q1 2026 | -$3.7M | +$1.4M |
| Q4 2025 | -$6.7M | -$904K |
| Q3 2025 | -$5.7M | -$1.4M |
| Q2 2025 | -$6.1M | -$2.8M |
| Q1 2025 | -$5.1M | -$5M |
| Q4 2024 | -$5.8M | -$5.3M |
DRK has burned cash in almost every quarter: −$20M over the past year, against −$23M the year before.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over DRK on cash generation, producing positive trailing cash flow while its opponent burns cash.
DRK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +71% | +3.7M shares |
| 1 year | +219% | +6.1M shares |
| 3 years | +8805% | +8.7M shares |
DRK has 9M diluted shares, up 219% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over DRK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
DRK Net Leverage
DRK's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
DRK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 5.2 | Oversold |
DRK's weekly RSI is 42 (neutral) and its Stochastic is 5 (oversold).
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
DRK PE vs Technology Sector
DRK has no meaningful PE right now: it lost money over the past year.
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
DRK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.18 | 24% below |
| 20 week MA | $2.26 | 27% below |
| 50 week MA | $2.34 | 29% below |
| 100 week MA | $4.61 | 64% below |
| 200 week MA | $10.8 | 85% below |
DRK is in a downtrend: it's below all five of its weekly moving averages, and 85% below its 200-week average.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has the edge over DRK on trend strength, trading above more of its moving averages.
DRK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.2 | $109.2 | +113% |
| 2021 | $109.2 | $247.8 | +127% |
| 2022 | $247.8 | $21.0 | -92% |
| 2023 | $21.0 | $33.2 | +58% |
| 2024 | $33.2 | $9.61 | -71% |
| 2025 | $9.61 | $3.61 | -62% |
| 2026 YTD | $3.61 | $1.66 | -54% |
DRK's yearly returns have swung widely, from +127% in 2021 to −92% in 2022. It's down 54% so far in 2026.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over DRK on returns for 2026, with the stronger performance.